18–75 years of age, male or female |
First time cardiac procedures |
Elective (scheduled >24 hours in advance) |
Coronary artery bypass grafting (CABG), aortic (AVR) or mitral valve repair or replacement (MVR), or combination of these procedures |
The ability to give consent |
Subjects were not included in the study for any of the following reasons |
Planned use of acute normovolemic hemodilution |
History of coagulation disorder |
Preoperative hematocrit (HCT) <30%, and/or platelet count <150,000/μL |
Ejection fraction <35% |
Renal insufficiency (creatinine >2.0 mg/dL) |
Recent (<7 days) use of anticoagulant or antiplatelet medications |
Recent myocardial infarction (<7 days) |
Current use of intra-aortic balloon counter-pulsation |
Surgical procedure requiring deep hypothermia circulatory arrest |
Ventricular assist device implantation |
Heart or lung transplantation |
Refusal to receive blood product transfusions |
Concurrent enrollment in another study |
Pregnancy |